The fate and risk of selected pharmaceutical and personal care products in wastewater treatment plants and a pilot-scale multistage constructed wetland system

2013 ◽  
Vol 21 (2) ◽  
pp. 1466-1479 ◽  
Author(s):  
Saichang Zhu ◽  
Hong Chen
2010 ◽  
Vol 62 (10) ◽  
pp. 2450-2458 ◽  
Author(s):  
Angela Yu-Chen Lin ◽  
Cheng-Fan Lin ◽  
Yu-Ting Tsai ◽  
Hank Hui-Hsiang Lin ◽  
Jie Chen ◽  
...  

Pharmaceuticals and personal care products (PPCPs) constitute a class of chemicals of emerging concern due to the potential risks they pose to organisms and the environment, even at low concentrations (ng/L). Recent studies have found that PPCPs are not efficiently removed in secondary wastewater treatment plants (WWTPs). This study has: (1) simultaneously investigated the occurrence of sixty-one PPCPs using solid phase extraction and high-performance liquid chromatography-tandem mass spectrometry, (2) evaluated removal efficiencies of target PPCPs in six WWTPs that discharge effluents into major Taiwanese rivers, and lastly (3) examined matrix interference during analysis of target PPCPs in water samples. The twenty target PPCPs were chosen for their high detection frequencies, high influent concentrations, and stability during wastewater treatment processes. Caffeine and acetaminophen were detected at the highest concentrations (as high as 24,467 and 33,400 ng/L) and were effectively removed (both >96%); other PPCPs were detected in the high ng/L range but were not effectively removed. Matrix interference (by ion suppression or enhancement) during the analysis resulted in underestimation of the removal efficiencies of erythromycin-H2O, cefazolin, clarithromycin, ibuprofen, diclofenac, clofibric acid and gemfibrozil.


Author(s):  
Alex Neumann

The increased use of Pharmaceuticals and Personal Care Products (PPCP’s) has led to an increase in many population health problems. In 1997, 15–50 % of women had developed breasts by the age of 8. Ten years prior to this, breast development by the age of 8 was uncommon. There are certain researchers who believe that this may be linked to the pharmaceuticals humans are consuming.Wastewater treatment plants are a significant gateway by which pharmaceuticals enter the water supply. Many pharmaceuticals find themselves in wastewater treatment plants, however the plants do not target these specific chemicals for treatment. As a result, they are released into the surrounding bodies of water, and accumulate in aquatic animals. When water treatment plants take water from the bodies of water and distribute it for human consumption, humans consume these chemicals.Many techniques for removing the pharmaceuticals have been tested, but there is still much uncertainty as to which are effective methods. The potential hazards associated with these chemicals are still uncertain, but the current evidence is indicating that it is very likely that these chemicals can be very hazardous.


2013 ◽  
Vol 2013 ◽  
pp. 1-10 ◽  
Author(s):  
George Tangyie Chi ◽  
John Churchley ◽  
Katherine D. Huddersman

The pollution of water sources by endocrine disrupting compounds (EDCs) and pharmaceutical and personal care products (PPCPs) is a growing concern, as conventional municipal wastewater treatment systems are not capable of completely removing these contaminants. A continuous stir tank reactor incorporating a modified polyacrylonitrile (PAN) catalyst and dosed with hydrogen peroxide in a heterogeneous Fenton’s process was used at pilot scale to remove these compounds from wastewater that has undergone previous treatment via a conventional wastewater treatment system. The treatment system was effective at ambient temperature and at the natural pH of the wastewater. High levels of both natural and synthetic hormones (EDCs) and PPCPs were found in the effluent after biological treatment of the wastewater. The treatment system incorporating the modified PAN catalyst/H2O2decomposed >90% of the EDCs and >40% of PPCPs using 200 mgL−1H2O2, 3 hr residence time. The estrogenic potency EE2-EQ was removed by 82.77%, 91.36%, and 96.13% from three different wastewater treatment plants. BOD was completely removed (below detection limits); 30%–40% mineralisation was achieved and turbidity reduced by more than 68%. There was a <4% loss in iron content on the catalyst over the study period, suggesting negligible leaching of the catalyst.


Sign in / Sign up

Export Citation Format

Share Document